What this means
Researchers plan to follow older adults over time to learn how Alzheimer's disease changes. The study is still recruiting, so no results are available yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 55–90
- Where
- 4 sites
The science
- Registered title
- Fuzhou Aging Brain Health Initiative
- Trial ID
- NCT07891429 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Dementia, Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
- What is tested
- Fluids biomarker and neuroimaging of AD diagnosis
- Sponsor
- Fujian Medical University Union Hospital
- Ages
- 55 Years to 90 Years
- Dates
- First posted Oct 23, 2026 · updated Oct 23, 2026
Registry summary
The goal of this observational study is to learn about the pathophysiological characterization and evolutionary patterns of Alzheimer's disease (AD) in older adults in Fujian Province, China. The primary purposes are as follows:
- establishment and follow-up of cohorts in the general population and populations with cognitive impairment;
- investigation of risk factors and evolutionary patterns of AD pathological characteristics;
- construction and validation of AD digital phenotypes based on multi-dimensional digital-intelligence screening;
- exploration of AD-related risk genes and their mechanisms of action;
- development of novel technologies for plasma biomarkers and PET imaging for the accurate diagnosis of AD.
Sites (4)
- Fuqing City Gaoshan Town Health Center, Fushun, Fujian, China
- Antai Street Community Health Service Center, Fuzhou, Fujian, China
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Huada Street Community Health Service Center, Fuzhou, Fujian, China